0001127602-20-032415.txt : 20201228
0001127602-20-032415.hdr.sgml : 20201228
20201228194632
ACCESSION NUMBER: 0001127602-20-032415
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201224
FILED AS OF DATE: 20201228
DATE AS OF CHANGE: 20201228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MACKAY GEOFFREY
CENTRAL INDEX KEY: 0001741849
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38537
FILM NUMBER: 201419764
MAIL ADDRESS:
STREET 1: C/O AVROBIO, INC.
STREET 2: ONE KENDALL SQ, BLDG. 300, STE. 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVROBIO, Inc.
CENTRAL INDEX KEY: 0001681087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 810710585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 300, SUITE 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7819626030
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 300, SUITE 201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AvroBio, Inc.
DATE OF NAME CHANGE: 20160729
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-12-24
0001681087
AVROBIO, Inc.
AVRO
0001741849
MACKAY GEOFFREY
C/O AVROBIO, INC.
ONE KENDALL SQUARE, BLDG. 300, SUITE 201
CAMBRIDGE
MA
02139
1
1
President & CEO
Common Stock
2020-12-24
4
M
0
100000
.4132
A
245123
D
Common Stock
72604
I
By daughter of reporting person
Common Stock
72604
I
By son of reporting person
Common Stock
200000
I
By The Geoff R. MacKay Irrevocable Trust
Stock Option (Right to Buy)
.4132
2020-12-24
4
M
0
100000
0
D
2026-04-12
Common Stock
100000
142013
D
This filing relates to the exercise of a Stock Option. No shares of Common Stock were sold by the Reporting Person, and the shares of Common Stock received upon exercise of the Stock Option are subject to a lock-up agreement with Morgan Stanley & Co. LLC and Cowen and Company, LLC.
25% of the shares vested on July 1, 2017, and the remaining 75% vest in equal quarterly installments thereafter over a three-year period.
/s/ Steven N. Avruch, Attorney-in-Fact for Geoffrey MacKay
2020-12-28